NCT06021041Active, not recruitingNot Applicable
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Tongji Hospital
- Enrollment
- 900
- Locations
- 2
- Primary Endpoint
- 2-year disability rate
Study Overview
Brief Summary
This is a retrospective clinical study to analyze the clinical characteristics, complications, and effects of different treatment options on long-term prognosis of severe tuberculosis patients. All cases of severe tuberculosis diagnosed between 2016 and 2021 were included in the electronic medical record system of one center, and data such as demographics, hospitalization information, clinical information, laboratory or imaging examinations, treatment plans, and outcomes were collected.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •For patients with severe pulmonary tuberculosis, imaging and grading diagnosis meet any of the following:
- •Damaged lung ≥ 1 lobe
- •Chest CT shows lesions in ≥3 lung lobes
- •Hematogenous disseminated pulmonary tuberculosis
- •caseous pneumonia
- •bronchial tuberculosis
- •Multiple hilar or mediastinal lymph node enlargement in primary pulmonary tuberculosis
- •Rifampicin-resistant, multidrug-resistant, polydrug-resistant or pan-drug-resistant tuberculosis
- •Combined more than 2 cavities over 8mm
- •Tuberculous massive hemoptysis
- •Pulmonary tuberculosis complicated with acute infection (including multidrug-resistant bacterial infection, fungal infection or multiple infection)
- •Combined with extrapulmonary tuberculosis
- •Intracranial tuberculosis, spinal cord and/or meningeal tuberculosis
- •Pleural effusion, pericardial effusion
- •Empyema or empyema, hemopneumothorax, tracheobronchopleural fistula and severe infection.
- •Heart failure caused by cardiac tamponade or constrictive pericarditis
- •Multiple sites of lymphatic tuberculosis or surgery is necessary
- •Cervical lymphatic tuberculosis
- •Mediastinal lymphatic tuberculosis
- •Abdominal or retroperitoneal lymph node tuberculosis
- •Abdominal tuberculosis, tuberculous peritonitis (ascites or multiple serous cavities)
- •Intestinal tuberculosis causes complete or incomplete intestinal root obstruction or perforation or massive bleeding or severe abdominal infection
- •Gastrointestinal hemorrhage caused by tuberculosis of the digestive system, etc.
- •Musculoskeletal tuberculosis
- •Spinal (cervical, thoracic, lumbar, sacral) tuberculosis
- •Bones in other parts
- •Merge surrounding abscess
- •Urinary or renal tuberculosis
- •Renal failure or damaged blood vessels caused by renal tuberculosis
- •Ureteral stenosis or blockage caused by urinary tuberculosis
- •Adrenal tuberculosis in hypoadrenal insufficiency
- •Liver tuberculosis
- •Age and gender are not limited.
Exclusion Criteria
- •Patients with no clear diagnosis at discharge.
- •Patients judged by the investigator to be unsuitable for inclusion in this protocol.
- •The discharge diagnosis was central nervous system tuberculosis, or tuberculous meningitis, or tuberculous cerebrospinal meningitis, or tuberculous meningoencephalitis, or tuberculous encephalitis, or tuberculous brain abscess, or spinal tuberculosis, or tuberculous Hydrocephalus, and is currently participating in other clinical studies.
Outcomes
Primary Outcomes
2-year disability rate
Time Frame: 2 years
2-year disability rate
2-year survival rate
Time Frame: 2 years
2-year survival rate
Secondary Outcomes
- The number of participants with the presence of clinical symptoms(2 years)
- Proportion of patients admitted to the ICU(2 years)
- Incidence of complications in patients with different treatment regimens(2 years)
- Length of hospital stay for patients(2 years)
Investigators
Qin Ning
Professor
Tongji Hospital
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System TuberculosisCentral Nervous System TuberculosisNCT06011915Tongji Hospital638
Completed
Not Applicable
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in BelgiumCarcinoma, Non-Small-Cell LungNCT03761901AstraZeneca141
Terminated
Not Applicable
HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and OutcomesBreast CancerNCT04396626Pfizer975
Completed
Not Applicable
RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.Breast CancerNCT04460898Pfizer195
Completed
Not Applicable
Treatment After Palbociclib-containing RegimensBreast CancerNCT04517318Fudan University200